Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity

Bullish:

• $LLY - Eli Lilly's Retatrutide (GLP-3) showing superior weight loss results with muscle sparing, positioned to dominate next-gen obesity treatment market despite gray market competition.

  • “Retta True Tide went through phase three at Lilly. People can lose up to a third of their body weight in a pretty short amount of time with some degree of muscle sparing.”

    Andrew·14:01

  • “It also seems to bypass some of the side effects that some of the previous GLPs created, although no drug is perfect, of course.”

    Andrew·14:12

  • “You can buy retreotide soon from Lilly.”

    Andrew·25:30
• $PHARMA - Massive adoption of GLP-1 drugs with 1 in 7 Americans taking them, predicting over half of Americans will be on these drugs in 5 years, representing a transformative market opportunity.

  • “Nearly one in seven Americans is taking a GLP-one drug. Twenty percent have tried them.”

    Daisy·0:17

  • “In theory, you could eradicate obesity.”

    Andrew·0:24

  • “I'm guessing that more than half, especially people who come from families or communities where there's a lot of obesity, are are gonna be taking them.”

    Andrew·15:22
• $BIOTECH - Peptide market expanding rapidly with multiple applications beyond GLPs, becoming mainstream like vitamins despite regulatory gray areas.

  • “I think in five years, you and I are going to have a little cocktail. It's going to be one injection or one pill, and it's going to be a little bit of pinealine at night combined with something else.”

    Andrew·29:46

  • “I think all of that stuff is going to be commonplace. The same way that people are not afraid of vitamin D, or they're taking some creatine, or magnesium”

    Andrew·34:30

  • “I think most everyone is going to be doing that. And I think the cost is going to be low enough that that statement, most everyone, is a real statement.”

    Andrew·34:47
• $HEALTHTECH - AI-powered health diagnostics becoming superior to average doctors, with companies building comprehensive health data platforms that can diagnose issues before symptoms appear.

  • “Chad GBT is already an incredible doctor, better than an average doctor an American can get access to.”

    Daisy·35:03

  • “function or building something that pulls in, you know, all of your health records from EHRs, all of your wearable data, all of your function blood test results, your imaging, and feeds it into this model in real time where it's going to diagnose issues with you before you even feel symptoms.”

    Daisy·35:15
• $WEARABLES - Wearable technology evolving from reading biology to writing/modifying it, with technologies coming that can directly control sleep, focus, and cognitive states.

  • “I think in five years, we're gonna look back and we'll be like, can you believe it? We were like cooling the room to try and fall asleep.”

    Andrew·29:46

  • “You wear an eye mask that's moving your eyes back and forth, and within six minutes or less, you'll be asleep.”

    Andrew·30:25

  • “I can imagine putting on a pair of glasses to sit down and do some work, and your visual field goes, and there's some sort of level of stimulation, external stimulation, that brings your ramps up your level of focus.”

    Andrew·38:33

Bearish:

• $TRADMEDIA - Traditional media losing credibility and relevance in health reporting, with declining standards and partisan coverage driving audiences away.

  • “I do think that there's been a real drop in standards of what we consider news.”

    Andrew·11:20

  • “It saddens me because it cheapens the entire health space.”

    Andrew·11:27

  • “I actually think that traditional media is is more to blame because are we really arguing about whether or not the food guidelines are are perfect?”

    Andrew·11:37

  • “podcast channels have become bigger than a lot of the at least in the health domain than the more traditional houses.”

    Andrew·10:32